Evidence map›Paper›PMID 22262950›Full record

ReviewTheScientificWorldJournal2011

Regulatory immunotherapy in bone marrow transplantation.

Vanessa Morales-Tirado, Wioleta Luszczek, Marié van der Merwe, Asha Pillai

Open access · goldAbstract readReview
In one paragraph

Review in TheScientificWorldJournal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vanessa Morales-TiradoDepartment of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.
Wioleta Luszczek
Marié van der Merwe
Asha Pillai
St. Jude Children's Research Hospital · US

Funding

REGULATORY T CELLS, MIXED CHIMERISM: A NOVEL TRANSPLANT STRATEGY FOR THALASSEMIASK08HL088260 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI PILLAI, ASHA BHASKARAN · 2008 to 2012
$653k
NHLBI NIH HHS 5K08HL088260NHLBI NIH HHS K08 HL088260
6 · The paper itself

Abstract

Every year individuals receive hematopoietic stem cell transplantation (HSCT) to eradicate malignant and nonmalignant disease. The immunobiology of allotransplantation is an area of ongoing discovery, from the recipient's conditioning treatment prior to the transplant to the donor cell populations responsible for engraftment, graft-versus-host disease, and graft-versus-tumor effect. In this review, we focus on donor-type immunoregulatory T cells, namely, natural killer T cells (NKT) and regulatory T cells (Treg), and their current and potential roles in tolerance induction after allogeneic HSCT.

Indexed as

ImmunotherapyTransplantation ToleranceAnimalsBone Marrow TransplantationHumansMiceModels, ImmunologicalNatural Killer T-CellsT-Lymphocytes, RegulatoryTransplantation, HomologousAllogeneic transplantationGVHDGVTimmunoregulationNKTregulatory T cellstransplant tolerance

Identifiers

PMID22262950
PMCPMC3254014
OpenAlexW2094147378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.